Tag Archives: autolus

January, 2015

  • 22 January

    Syncona and UCL Business Form Cancer Immunotherapy Company Autolus

    Backed with roughly $45.5 million, Investment company Syncona and UCL Business, the wholly-owned technology transfer company of University College London, have launched the latest CAR T upstart, Autolus Limited. According to the companies, Autolus is a biopharmaceutical company focused on the development and commercialization of next-generation engineered T-cell therapies for …